Ozempic Shows 50% Cancer Risk Drop in New Studies

Over 40 studies presented at a major cancer conference reveal that GLP-1 drugs like Ozempic and Wegovy may dramatically reduce cancer risk across multiple types.

The findings suggest these medications protect against cancer through both weight loss and powerful anti-inflammatory effects.